NOVEL THERAPEUTICS TARGETING BET-MEDIATED ONCOGENESIS IN LETHAL PROSTATE CANCER

$1,729,963FY2025Defense Health AgencyDOD

University Of California, Davis

Investigators

View source on USAspending →